Skip to content

Safety and Efficacy Study of Myopia Control Devices in Children and Adolescents

Safety and Efficacy Study of Myopia Control Devices in Children and Adolescents

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115755
Enrollment
Unknown
Registered
2025-12-30
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myopia

Interventions

experimental group:Wear defocused frame glasses (HOYA Xin Le Xue lenses)+myopia treatment device
control group:Wear defocused frame glasses (HOYA Xin Le Xue lenses)

Sponsors

Eye Hospital, Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 1 Years

Inclusion criteria

Inclusion criteria: 1. Age 6 to 12 years old at the time of enrolment, gender is not limited; 2. Those who were diagnosed with myopia according to the Guidelines for Prevention and Treatment of Myopia of the General Office of the National Health Commission (Medical Letter of the National Health Office [2024] No. 168); 3. -0.75D= 5.0 in both eyes; 7. No other organic lesions affecting vision in both eyes; 8. Subjects and guardians can understand the purpose of this trial and sign an informed consent form; subjects can cooperate with the treatment and related ophthalmological examinations, and do not take other myopia prevention and control measures other than the study protocol during the whole study period;

Exclusion criteria

Exclusion criteria: 1. Diagnosed as having overt strabismus; 2. Far range oblique deviation+1 prism degree, close range oblique deviation0 prism degree; 3. Congenital color vision impairment (color blindness); 4. Any eye disease, ophthalmic surgery (including strabismus surgery), systemic or other diseases that may be related to myopia or affect refractive development, such as Marfan syndrome, retinopathy of premature infants, diabetes; 5. Eye injuries or corneal, conjunctival, or eyelid diseases (including keratoconus and herpetic keratitis) that have been assessed by researchers to affect the research results, as well as fundus lesions; 6. Other myopia prevention and control measures have been taken within the past 3 months, except for optical monocular lenses; 1.Have undergone binocular vision training within 7.1 months; 2.Conducted flip shooting training within 2 weeks; 8. Fear of light or inability to open eyes normally; 9. Any physiological structure, skin or other condition that may affect the wearing of glasses; 10. Participated in other clinical trials 4 weeks before enrollment; 11. The subjects suffer from acute or chronic diseases (including other currently existing acute or chronic pain) or mental illnesses, which may increase the risks associated with participating in the study or using experimental products, or may affect the interpretation of the study results. Based on the judgment of the researchers or designated personnel with medical qualifications, these conditions make the subjects unsuitable for inclusion in this study.

Design outcomes

Primary

MeasureTime frame
axial length;

Secondary

MeasureTime frame
spherical equivalent lens after pupil dilation;choroidal thickness;Best corrected visual acuity(BCVA);Fundus photography;The morphological structure of each layer of the retina;Equipment defect rate;Adverse event incidence rate;

Countries

China

Contacts

Public ContactJie Chen

Eye Hospital, Wenzhou Medical University

cjie@sunyopt.edu+86 577 88068817

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026